SCHEMBL3564812

SCHEMBL3564812

CC[Si](CC)(CC)c1cc2cccnc2o1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMD14 O00487 2/20 0.34
COPS5 Q92905 2/20 0.34
CYP2A6 P11509 1/20 0.34
ALDH1A1 P00352 5/20 0.33
CCR1 P32246 3/20 0.32
CCR8 P51685 3/20 0.32
KDM4E B2RXH2 3/20 0.32
CCR5 P51681 2/20 0.32
MAPT P10636 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
GMNN O75496 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MMP2 P08253 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MMP9 P14780 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9277705 0.75 SGMS2 (0.36) PSMD14COPS5CYP2A6ALDH1A1CCR1
SCHEMBL15638227 0.73 FLT3 (0.44) CYP2A6ALDH1A1KDM4EMAPTTDP1
SCHEMBL20181538 0.72 TLR8 (0.50) CYP2A6ALDH1A1CCR1CCR8KDM4E
SCHEMBL128666 0.72 ALDH1A1 (0.42) PSMD14COPS5CYP2A6ALDH1A1CCR1
SCHEMBL2624387 0.69 CCR1 (0.37) PSMD14COPS5CYP2A6ALDH1A1CCR1
SCHEMBL15966361 0.68 HTT (0.42) ALDH1A1CCR1CCR8KDM4ECCR5
SCHEMBL16901678 0.68 ALDH1A1 (0.42) ALDH1A1CCR1CCR8KDM4ECCR5
SCHEMBL18660657 0.68 HTT (0.38) PSMD14COPS5ALDH1A1CCR1CCR8
SCHEMBL3574183 0.68 PTGES (0.51) ALDH1A1KDM4EALOX15TSHRNPC1
SCHEMBL15935208 0.68 ALDH1A1 (0.35) PSMD14COPS5CYP2A6ALDH1A1CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674907-B2 Furanopyridine derivatives and methods of use AMGEN INC. (US) 2010-03-09 US disclosed
US-20060046977-A1 Furanopyridine derivatives and methods of use AMGEN INC. 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060046977-A1 Furanopyridine derivatives and methods of use LCK, NFATC1, MINK1 PSMD14 3340/4885COPS5 3853/4885CYP2A6 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.